Egetis Therapeutics’ Shares Offering

Vinge advised Egetis Therapeutics on the deal. Egetis Therapeutics AB (publ), listed on Nasdaq Stockholm, completed a directed share issuances whereby Egetis Therapeutics receives gross proceeds...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Irisity’s Rights Offering

Vinge advised Irisity on the offering. Irisity AB (publ) completed its rights issuance of units consisting of shares and warrants. The issue is guaranteed to 80...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

UBE Corporation’s Acquisition of LANXESS

Baker McKenzie advised UBE Corporation on the deal. UBE Corporation, a Japanese chemical company based in Tokyo, secured the acquisition of LANXESS’ Urethane Systems business (LANXESS...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here